Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Exploring the immune profile of chronic hand eczema

Official title: Characterization of the Immune Signature of Chronic Hand Eczema With an Innovative Approach Combining Spatial Transcriptomics and Single Cell Spatial Proteomics

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06884163 · Data updated 2026-11-12

This study is trying to understand the immune system's response in adults with chronic hand eczema to help create better, personalized treatments.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Rome)
StatusRecruiting
StartedJanuary 13, 2025
Main results expectedJanuary 1, 2026
Study endsJanuary 1, 2027
Registry record updatedMarch 19, 2025
Trial IDNCT06884163 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 with chronic hand eczema lasting at least 3 months or experiencing multiple flare-ups in the past year.

Probably not a fit

Patients currently using immunosuppressants or systemic corticosteroids may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the immune landscape of chronic hand eczema through advanced techniques like spatial transcriptomics and single-cell proteomics. It includes patients aged 18 to 65 with chronic hand eczema, assessing disease severity using validated scores and conducting skin biopsies for diagnosis confirmation. The research aims to identify distinct inflammatory cell subgroups and molecular markers that characterize the immune response in various subtypes of chronic hand eczema, potentially leading to more personalized treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to more effective and tailored therapies for patients suffering from chronic hand eczema.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in understanding immune responses in other dermatological conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients affected with chronic hand eczema of endogenous and/or exogenous origin, age from 18 to 65 years
* Patients affected with eczema located on the hands for at least 3 months or with ≥ 2 disease flare-ups in the last year.
* Patients affected with atopic dermatitis affecting the hands and other areas of the body, provided the eczema lesions involve less than 30% of the body surface area.

Exclusion Criteria:

* Concurrent or previous treatment with immunosuppressants, except for short courses of systemic corticosteroids (less than one month of continuous treatment), or biologic agents that may affect the clinical aspects or progression of chronic hand eczema.
* Patients who have received systemic corticosteroids within one month prior to enrollment in the study.
* Patients using topical corticosteroids or calcineurin inhibitors within one week of study enrollment (this time frame is considered to provide a good balance between potential residual pharmacological effects and ethical considerations).
* Patients with chronic hand eczema of mixed etiology (e.g., allergic and atopic) or those considered "etiologically unclassifiable" will not be included in the data analysis.

Where it's running

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Rome, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.